Cite
HARVARD Citation
Fuso, L. et al. (n.d.). Gemcitabine–carboplatin–paclitaxel combination as first-line therapy in advanced ovarian carcinoma: a single institution phase II study in 24 patients. International journal of gynecological cancer. pp. 60-67. [Online].